IFN-γ affects homing of diabetogenic T cells

被引:85
作者
Savinov, AY
Wong, FS
Chervonsky, AV
机构
[1] Jackson Lab, Bar Harbor, ME 04609 USA
[2] Univ Bristol, Sch Med Sci, Dept Pathol, Bristol BS8 1TD, Avon, England
[3] Univ Bristol, Sch Med Sci, Dept Microbiol, Bristol BS8 1TD, Avon, England
关键词
D O I
10.4049/jimmunol.167.11.6637
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IFN-gamma is a cytokine with pleiotropic functions that participates in immune and autoimmune responses. The lack of IFN-T is known to delay the development of autoimmune diabetes in nonobese diabetic (NOD) mice. Splenocytes from diabetic NOD and IFN-gamma knockout (KO) NOD mice transfer diabetes into NOD recipients equally well. However, adoptive transfer of diabetogenic T cells from NOD mice into NOD.IFN-gamma -KO or NOD mice lacking beta -chain of IFN-gamma receptor (NOD.IFN-gammaR beta -KO) appeared to be much less efficient. We found that IFN-gamma influences the ability of diabetogenic cells to penetrate pancreatic islets. Tracing in vivo of insulin-specific CD8(+) T cells has shown that homing of these cells to the islets of Langerhans was affected by the lack of IFN-gamma. While adhesion of insulin-specific CD8(+) cells to microvasculature was normal, the diapedesis was significantly impaired. This effect was reversible by treatment of the animals with rIFN-gamma. Thus, IFN-gamma may, among other effects, influence immune and autoimmune responses by supporting the homing of activated T cells.
引用
收藏
页码:6637 / 6643
页数:7
相关论文
共 56 条
[1]   The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse [J].
Ablamunits, V ;
Elias, D ;
Cohen, IR .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 115 (02) :260-267
[2]   IL-1α, IL-1β, and IFN-γ mark β cells for Fas-dependent destruction by diabetogenic CD4+ T lymphocytes [J].
Amrani, A ;
Verdaguer, J ;
T'hiessen, S ;
Bou, S ;
Santamaria, P .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (04) :459-468
[3]   Cellular responses to interferon-gamma [J].
Boehm, U ;
Klamp, T ;
Groot, M ;
Howard, JC .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :749-795
[4]   Regulation of development and function of memory CD4 subsets [J].
Bradley, LM ;
Harbertson, J ;
Freschi, GC ;
Kondrack, R ;
Linton, PJ .
IMMUNOLOGIC RESEARCH, 2000, 21 (2-3) :149-158
[5]   Modulation of PECAM-1 (CD31] expression in human endothelial cells:: Effect of IFNγ and IL-10 [J].
Buján, J ;
Gimeno, MJ ;
Prieto, A ;
Pascual, G ;
Bellón, JM ;
Alvarez-Mon, M .
JOURNAL OF VASCULAR RESEARCH, 1999, 36 (02) :106-113
[6]   ESSENTIAL ROLE FOR INTERFERON-GAMMA AND INTERLEUKIN-6 IN AUTOIMMUNE INSULIN-DEPENDENT DIABETES IN NOD/WEHI MICE [J].
CAMPBELL, IL ;
KAY, TWH ;
OXBROW, L ;
HARRISON, LC .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :739-742
[7]   CLASS-II TRANSACTIVATOR REGULATES THE EXPRESSION OF MULTIPLE GENES INVOLVED IN ANTIGEN PRESENTATION [J].
CHANG, CH ;
FLAVELL, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :765-767
[8]   Apoptotic and effector pathways in autoimmunity [J].
Chervonsky, AV .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (06) :684-688
[9]   The role of Fas in autoimmune diabetes [J].
Chervonsky, AV ;
Wang, Y ;
Wong, FS ;
Visintin, I ;
Flavell, RA ;
Janeway, CA ;
Matis, LA .
CELL, 1997, 89 (01) :17-24
[10]   IMMUNOHISTOCHEMICAL DEMONSTRATION OF C-ERBB-2 ONCOPROTEIN IN GASTRIC ADENOCARCINOMA - COMPARISON OF CRYOSTAT AND PARAFFIN WAX SECTIONS AND EFFECT OF FIXATION [J].
CHIU, KY ;
LOKE, SL ;
HO, FCS .
JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (02) :117-121